Alexion Pharmaceuticals, INC.
Biopharmaceutical Company.
Based in MA
🤖
AI Overview
With $2.0M in lobbying spend across 26 quarterly filings, Alexion Pharmaceuticals, INC. is a significant lobbying presence.
$2.0M
Total Lobbying Spend
26
Quarterly Filings
1
Lobbying Firms Used
9
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2020 | $180K |
| 2021 | $390K |
| 2022 | $480K |
| 2023 | $280K |
| 2024 | $400K |
| 2025 | $240K |
Lobbying Firms
TODD STRATEGY GROUP
What They Lobby For
- Home Infusion. COVID-19 Response.
- COVID-19 Response.
- Home Infusion. Patient-Centered Outcomes Research Institute Nominations.
- Home Infusion. Medicare Reimbursement for New Technologies.
- Rare disease designation. H.R.5376 - Build Back Better Act. H.R.3684 - Infrastructure Investment and Jobs Act.
- Medicare Reimbursement for New Technologies.
- Employee Retirement Income Security Act (ERISA) issues.
- Medicare Reimbursement for New Technologies. 340B. Home Infusion for Part B Products. H.R.830 - HELP Copays Act.
- General issues related to rare disease and orphan drugs. Diagnostics for patients with rare disease. Multi-Cancer Early Detection.
- 340B. Home Infusion for Part B Products. H.R.830 - HELP Copays Act.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.